These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8290014)

  • 1. Hepatitis-associated improvement of anemia in an anephric patient without elevation of serum erythropoietin level.
    Navarro JF; Teruel JL; Villafruela JJ; Ortuño J
    Nephron; 1993; 65(3):495-6. PubMed ID: 8290014
    [No Abstract]   [Full Text] [Related]  

  • 2. Variations of recombinant human erythropoietin application in hemodialysis patients.
    Bommer J; Samtleben W; Koch KM; Baldamus CA; Grützmacher P; Scigalla P
    Contrib Nephrol; 1989; 76():149-56; discussion 156-8. PubMed ID: 2684517
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum erythropoietin and interleukin-6 levels in hemodialysis patients with hepatitis virus infection.
    Radovic M; Jelkmann W; Djukanovic L; Ostric V
    J Interferon Cytokine Res; 1999 Apr; 19(4):369-73. PubMed ID: 10334388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term persistence of improvement of renal anaemia in spite of discontinued erythropoietin treatment.
    Wiecek A; Kokot F; Marcinkowski W
    Nephron; 1995; 69(4):489-90. PubMed ID: 7777122
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum erythropoietin titers in the anemia of chronic renal failure and other hematological states.
    Urabe A; Saito T; Fukamachi H; Kubota M; Takaku F
    Int J Cell Cloning; 1987 May; 5(3):202-8. PubMed ID: 3598244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and side effects of erythropoietin used in the treatment of anemia of uremic rats.
    Gretz N; Lasserre J; Kraft K; Waldherr R; Weidler B; Meisinger E; Strauch M
    Contrib Nephrol; 1988; 60():236-44. PubMed ID: 3345672
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
    ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of recombinant erythropoietin on sexual function in hemodialysis patients.
    Schaefer RM; Kokot F; Heidland A
    Contrib Nephrol; 1989; 76():273-81; discussion 281-2. PubMed ID: 2684527
    [No Abstract]   [Full Text] [Related]  

  • 9. Exceptionally high serum erythropoietin activity in an anephric patient with severe anemia.
    Ortega JA; Malekzadeh MH; Dukes PP; Ma A; Pennisi AV; Fine RN; Shore NA
    Am J Hematol; 1977; 2(3):299-306. PubMed ID: 596371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium acetate versus calcium carbonate and erythropoietin dosages in haemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Nephrol Dial Transplant; 1995 Dec; 10(12):2321-4. PubMed ID: 8808233
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hematologic changes in chronic uremia].
    Schnurr E
    Dtsch Med Wochenschr; 1979 Nov; 104(47):1678-82. PubMed ID: 510197
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of an erythropoietic inhibitor from the dialysate collected in the hemodialysis with PMMA membrane (BK-F).
    Yamada S; Kataoka H; Kobayashi H; Ono T; Minakuchi J; Kawano Y
    Contrib Nephrol; 1999; 125():159-72. PubMed ID: 9895438
    [No Abstract]   [Full Text] [Related]  

  • 13. Anemia in dialysis: its relation to acquired cystic kidney disease and serum levels of erythropoietin.
    Férnandez A; Hortal L; Rodríguez JC; Vega N; Plaza C; Palop L
    Am J Nephrol; 1991; 11(1):12-5. PubMed ID: 2048573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anemia of uremia: erythropoietin and bone marrow culture studies.
    Hanna W; Dunn CD; Smith LN
    J Tenn Med Assoc; 1980 Jul; 73(7):492-3. PubMed ID: 7421192
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.
    McGonigle RJ; Boineau FG; Beckman B; Ohene-Frempong K; Lewy JE; Shadduck RK; Fisher JW
    J Lab Clin Med; 1985 Apr; 105(4):449-58. PubMed ID: 3981057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum erythropoietin (ESF) titers in anemia of chronic renal failure.
    de Klerk G; Wilmink JM; Rosengarten PC; Vet RJ; Goudsmit R
    J Lab Clin Med; 1982 Nov; 100(5):720-34. PubMed ID: 7130829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum erythropoietin concentration before and after partial correction of renal anemia].
    Radtke HW; Erbes PM; Koch KM
    Verh Dtsch Ges Inn Med; 1978; (84):1279-81. PubMed ID: 741948
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemo-rheologic changes following treatment with human recombinant erythropoietin in chronic hemodialysis patients].
    Melappioni M; Giansanti R; Boemi M; Baldassari M; Baldini S; Pierangeli T; Radicioni R; Fumelli P; Panichi N
    Minerva Urol Nefrol; 1992; 44(2):155-9. PubMed ID: 1411865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.